And all opioids are Schedule II and require a controlled substance script along with a pain regiment plan. Doctors are under TONS of pressure to not cut Rx's for opioids. Even when it fits because the FDA/ATF will pull their license if they cut too many scripts in a single month. There's a monthly allotment.
You're right, meth actually isn't sold by pharmacies. I was just speaking off-handedly about drugs like Adderall which are amphetamine salts. Similar effects, less dangerous.
I've had family members under opiod Rxs for long periods of time for chronic pain. What's funny about that is although they don't want to cut them, they also don't really seem keen to give out more than the bars minimum, even for post surgery pain management. Mom had to buy more off the street because they didn't account for her tolerance, and when she brought it up, they pretty much said "too bad, junkie."
That is really interesting that they are under so much pressure. Says a lot about the state of pharma.
We have to defend the pharmaceutical industry. They are weak and vulnerable!
What would we do without big pharma prescribing opium and meth to everyone? I mean, could you think about how horrible that would be?
You know Meth is a Schedule I drug right?
It's illegal to write an Rx for it.
And all opioids are Schedule II and require a controlled substance script along with a pain regiment plan. Doctors are under TONS of pressure to not cut Rx's for opioids. Even when it fits because the FDA/ATF will pull their license if they cut too many scripts in a single month. There's a monthly allotment.
You're right, meth actually isn't sold by pharmacies. I was just speaking off-handedly about drugs like Adderall which are amphetamine salts. Similar effects, less dangerous.
I've had family members under opiod Rxs for long periods of time for chronic pain. What's funny about that is although they don't want to cut them, they also don't really seem keen to give out more than the bars minimum, even for post surgery pain management. Mom had to buy more off the street because they didn't account for her tolerance, and when she brought it up, they pretty much said "too bad, junkie."
That is really interesting that they are under so much pressure. Says a lot about the state of pharma.